bioworld.com

February’s phase III wins include Qyuns’ ankylosing spondylitis data

Biopharma clinical updates February 2025

In February 2025, BioWorld recorded 148 updates from phase I to phase III trials, marking a decline from the 171 updates tracked in January. The month saw 13 positive phase III trial results, while three studies ended in failure.

BioWorldAnalysis and data insightClinical

Read full news in source page